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KAJIAN TERHADAP MUTASI GEN GJB2 DAN GJB6 DI KALANGAN 
PESAKIT MELAYU YANG MENGALAMI KECACATAN PENDENGARAN 
JENIS TIDAK SINDROMIK 
 
ABSTRAK 
 
Kecacatan pendengaran merupakan kecacatan deria yang paling kerap berlaku pada 
manusia. Lebih kurang satu daripada seribu bayi yang baru dilahirkan di seluruh dunia 
lahir dengan kecacatan pendengaran samada dengan darjah kecacatan pendengaran yang 
ringan atau tiada pendengaran langsung. Kecacatan ini boleh disebabkan oleh dua faktor 
iaitu faktor genetik dan persekitaran dengan lebih 50% daripada kecacatan tersebut 
disebabkan oleh faktor genetik. Telah terbukti bahawa terdapat pelbagai gen yang 
terlibat dalam penyakit kecacatan pendengaran tidak sindromik (NSHL) iaitu sejenis 
kecacatan pendengaran tanpa gejala lain dan gen tersebut dikaji dalam penyelidikan ini. 
Mutasi pada gen GJB2 telah dikenal pasti sebagai gen utama yang terlibat dengan 
kecacatan pendengaran tidak sindromik (NSHL). Satu gen lain yang berkaitan iaitu gen 
GJB6 yang terletak berhampiran dengan gen GJB2 pada kromosom mungkin berkaitan 
dengan kecacatan pendengaran jenis NSHL. Tujuan kajian ini adalah untuk 
mengenalpasti mutasi pada dua gen tersebut dan perkaitannya dengan kecacatan 
pendengaran jenis NSHL. Sebanyak 91 sampel sel tisu pipi pesakit NSHL dan 91 
sampel sel tisu pipi subjek kawalan di Kelantan diambil untuk kajian ini. Tindak balas 
rantaian polimerase (PCR) digunakan untuk menggandakan gen GJB2. Produk PCR gen 
GJB2 seterusnya disaring untuk mutasi dengan menggunakan teknik DHPLC dan 
xviii 
 
mutasi yang berjaya dikesan kemudiannya disah tentukan dengan penjujukan DNA. 
Sebelas mutasi dan polimorfisma dikenal pasti pada 32 pesakit dan 37 subjek kawalan 
setelah sebanyak 182 pesakit NSHL dan kawalan disaring. Walaubagaimanapun, semua 
mutasi dan polimorfisma tidak menunjukkan hubungan statistik secara signifikan 
dengan NSHL dan darjah kecacatannnya. Bagi gen GJB6, pemotongan gen dikenal 
pasti dengan menggunakan teknik pelbagai PCR yang mana gen β-globin digunakan 
sebagai kawalan dalaman. Semua 182 pesakit dan kawalan telah dikenal pasti tidak 
mempunyai pemotongan gen GJB6 walaupun di antara mereka mempunyai mutasi gen 
GJB2 pada satu alel, dua alel atau tidak. Kami percaya bahawa pengambilan sampel 
yang lebih banyak dan menyaring seluruh gen GJB2 dan GJB6 serta gen lain yang 
berkaitan akan membantu mengenal pasti dan mengesahkan hubung kait antara mutasi 
dan polimorfisma dengan darjah kecacatan pendengaran.   
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A STUDY ON GJB2 AND GJB6 GENE MUTATIONS AMONG MALAYS WITH 
NON-SYNDROMIC HEARING LOSS 
 
ABSTRACT 
 
Hearing loss is the most common congenital sensory defects in human. About one in a 
thousand newborn in the world is born with the abnormality, which may vary from mild 
level of hearing loss to profound loss. This loss can be caused by two factors, genetic 
and environmental factors and more than 50% of the defect is due to genetic causes. It 
has been proven that multi genes are involved in non-syndromic hearing loss (NSHL), a 
type of hearing loss without other symptoms and covered in this study. Mutations in 
GJB2 gene have been shown to be a major role for congenital NSHL. A related gene, 
GJB6 which is located adjacent to GJB2 might be related and associated with NSHL. 
The objectives of this study are to identify the mutations in the two genes and study the 
association with NSHL. A total of 91 buccal cell samples of NSHL patients and 91 
normal volunteer buccal cells samples in Kelantan were taken for this study. 
Polymerase chain reaction (PCR) was used to amplify the coding region of GJB2 gene. 
The PCR product of GJB2 coding region was preceded with screening for mutations 
using denaturing High Performance Liquid Chromatography (dHPLC) and mutations 
detected were confirmed by DNA sequencing. Eleven sequence variations including 
mutations and polymorphisms were found in 32 patients and 37 control subjects after 
182 NSHL patients and controls were screened. However, all the variations did not 
show any statistically significant association with NSHL and the severity. For GJB6 
xx 
 
gene coding region, the deletion was identified by multiplex PCR assay whereby β-
globin gene was used as internal control. All 182 patients and controls were found to 
have no deletion of GJB6 coding region irrespective of whether they have genetic 
variation in GJB2 or not. Consequently, it is believed that a larger sample size and 
screening all regions in GJB2 and GJB6 and other related genes are necessary to verify 
the possible association between the mutations and polymorphisms and the severity of 
hearing loss in patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER 1 
   
 
INTRODUCTION 
 
1.1 Hearing loss 
 
Hearing loss happens when someone could not hear voices and sounds due to problems 
with one or more parts of the ear or ears. It is also called hearing impairment or 
deafness. Since they are unable to hear their own voices when they do try to speak, they 
therefore cannot imitate themselves (Martin and Grover, 1986). 
 
One in a thousand babies is born with hearing loss, making it the most common sensory 
type of birth defect (Watkin, 1996; Watkin and Baldwin, 1999). A study done by 
Abdullah et al., (2006) in Hospital Universiti Kebangsaan Malaysia (HUKM), Malaysia 
showed that the prevalence of hearing loss is 0.42%. Hearing loss can be due to 
environmental factors and genetic defects. Fifty one percent of hearing loss cases are 
caused by genetic factors and 77% are inherited in an autosomal recessive pattern 
(Morton, 1991). To date, it is believed that more than a hundred genes may be involved 
in hearing loss with several of these genes have been identified; two of them are gap 
junction protein beta-2 (GJB2) gene and gap junction protein beta-6 (GJB6) gene (Van 
Camp and Smith, 1999). 
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1.2 Hearing – How it works 
 
Our ear is made up of three different sections; outer ear, middle ear and inner ear. Each 
section has a specific function. The outer ear collects sound waves and the middle ear 
converts the sound energy into a mechanical force, then it is transmitted to the inner ear 
thus converting it to electrical energy and sent via the auditory nerve to the brain 
(Freeland, 1989). 
 
The outer ear comprises of pinna, which is shaped like a shell and its function is to pick 
up sound waves. The pinna leads to the ear-canal at the bottom of which the eardrum 
(tympanic membrane) is located. The ear drum is the division between the outer and 
middle ears (Freeland, 1989).  
 
The middle ear is an air-containing space which contains three unusually shaped 
ossicles; the malleus (hammer), incus (anvil) and stapes (stirrup). The sound waves 
received by the eardrum will cause the vibration and this vibration will pass through the 
malleus, incus and stapes, thus converting sound energy into mechanical energy. This 
energy is directed on to a membrane (oval window) to which the stapes is connected 
and which is 22 times smaller than the size of the eardrum. The chain of ossicles thus 
acts as much as a hydraulic press; it magnifies 22-fold the small pressures on the 
surface of the eardrum and transmits them to the oval window, then sends the 
mechanical energy into the inner ear for conversion into electrical activity (Freeland, 
1989). 
3 
 
The inner ear is an extraordinarily complicated mechanism, comprises a coiled structure 
called the cochlea. One end of the cochlea is connected to the oval window; the other 
end is also in contact with another part of the middle ear through another membrane 
called the round window. The inner ear filled with fluid and when the stapes moves, a 
ripple is sent right through the fluid of the inner ear to the round window. The 
movement of the inner ear fluid deflects a thin membrane in the centre of the cochlea 
called basilar membrane. Delicate cells like tiny hairs balance on this membrane (the 
organ of Corti) and connect directly to a multitude of nerve endings, which join together 
to form the auditory nerve (Freeland, 1989) (Figure 1.1). 
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Figure 1.1: Cross-section of the outer, middle and inner human ear 
(http://www.dizziness-and-balance.com/disorders/hearing/hearing.html) 
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1.3 Degree of hearing loss 
 
Hearing loss or deafness (and sound in general) is measured in decibels (dB). Hearing 
loss can be classified in different degrees according to the intensity: mild (30 to 45 dB), 
moderate (50 to 65 dB), severe (70 to 90 dB) and profound (>95 dB). Table 1.1 shows 
the relationship between the decibel hearing loss and degree of difficulty it may cause 
(Martin and Grover, 1986). 
 
1.3.1 Pure Tone Audiometry (PTA) 
 
Pure tone audiometry is pure tone test to determine the type and degree of hearing loss 
for both right and left ear. PTA is a behavioral test used to measure hearing sensitivity 
(Kurtz Jr, 1994) (Figure 1.2). A calibrated machine called an audiometer is used to 
present tones at different frequencies (pitches) and at different intensity (loudness) 
level. The responses from the emitted sounds are recorded and plotted on a graph called 
an audiogram. The frequency of the sound is referred to in Hertz (Hz) while the 
intensity is measured in decibels (dB). The PTA testing is done between frequency 125 
and 8000 Hz. Once the audiogram is completed, the audiologist computes the pure tone 
average for each ear. It is the average of hearing thresholds at 500, 1000, and 2000 Hz, 
which are considered to be the major frequencies for speech. The pure-tone average 
represents the degree of hearing loss in decibels, not a percentage 
(http://www.asha.org/public/hearing/testing/assess.htm).  
 
6 
 
 
 
Figure 1.2: Examples of pure tone audiogram. (a) Scale of degrees of hearing 
level (http://www.springvalleyhearingctr.com/hearingassessment) (b) The 
audiogram in the illustration reveals a hearing loss for tones above 500 Hz 
(http://content.answers.com/main/content/img/McGrawHill/Encyclopedia/image
s/CE062100FG0010.gif) 
 
a 
b 
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1.4 Types of hearing loss 
 
Classification of hearing loss is based on the localization of the point at which the 
auditory pathway has broken down. It determines whether the patients‟s hearing loss is 
conductive, sensorineural, central, and functional or a combination of these (Sataloff 
and Sataloff, 2005). 
 
Conductive hearing loss is caused by any condition that interferes in the transmission of 
sound through the external and middle to the inner ear. If the damage is in the middle 
ear, it may involve the stapes, as in otosclerosis or the mobility of the eardrum and 
ossicles caused by fluid (Sataloff and Sataloff, 2005). Hearing tests on patient with 
conductive hearing loss show the inner ear or nerve function to be normal but air 
conduction to be reduced (Freeland, 1989). Most patients with this type of loss have a 
mild degree of loss, correctable and can be improved by medical treatment (i.e. 
surgical) (Ballantyne, 1993; Sataloff and Sataloff, 2005). 
 
Sensorineural hearing loss happens when inner ear or auditory nerve or both is/are 
damaged. The term „sensory‟ hearing loss is applied when the damage is localized in 
the inner ear while „neural‟ implies the damage is in auditory nerve. The cochlea has 
~30 000 hair cells that connect with nerve endings. The tiny hair cells could be 
damaged from a variety of causes. In the majority of cases, the loss is not curable 
(Sataloff and Sataloff, 2005). 
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In central hearing loss the damage is situated in central nervous system. The damage 
may be at any point from auditory nuclei in the medulla oblongata to the cortex. 
Formerly, central hearing loss was described as a type of „perceptive deafness‟ (Sataloff 
and Sataloff, 2005). 
 
Functional hearing loss is described when there is no detectable organic damage to 
auditory pathways but some underlying psychological or emotional problem is at fault 
(Sataloff and Sataloff, 2005). 
 
Patients, who experienced two or more types of hearing impairment, are described as 
having mixed hearing loss. However, for practical purposes this term is used only when 
conductive hearing loss accompanied by a sensory or a neural (or a sensorineural) loss 
in same ear (Sataloff and Sataloff, 2005). 
 
 
 
 
 
 
 
 
 
 
9 
 
Table 1.1: The effect of the different degrees of hearing loss (Martin and Grover, 1986) 
Decibels of hearing loss Degree of impairment Practical effect on hearing 
Up to 25 
30 – 45 
50 – 65 
70 – 90 
 
Over 95 
Within normal range 
Mild 
Moderate 
Severe 
 
Profound 
Little effect 
Difficulty with quiet voices 
Difficulty with many sounds 
Cannot hear speech without a 
hearing aid 
Can hear only a little even 
with a powerful hearing aid 
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1.5 Non-syndromic hearing loss (NSHL) 
 
Hearing loss is a symptom of many injuries and diseases. Therefore, it may expressed at 
any age and classified in many ways, such as genetic vs. acquired, syndromic vs. non-
syndromic, prelingual vs. postlingual, and conductive vs. sensorineural (Morton, 1991). 
 
Hearing loss can be due to environmental factors, genetic defects or a combination of 
these factors. Approximately 25% of children with hearing loss in the United States 
(U.S) are caused by environmental factors, such as prematurity, infections, exposure to 
ototoxic medications and trauma. It is estimated that at least 50% of prelingual hearing 
loss is caused by genetic changes, whereas the etiology remains obscure in the 
remaining 25%. Most of the cases, however, are assumed to be of genetic origin. Thus, 
genetic causes account for the largest proportion of all cases of prelingual hearing loss 
(Avraham, 2001). 
 
Clinically, hearing loss may be associated with other disorders in the form of syndromic 
hearing loss or as an isolated finding, non-syndromic hearing loss. However, both 
syndromic and non-syndromic phenotypes can result from the mutation in the same 
gene (e.g MYO7A, PDS). Syndromic hearing loss tends to be less genetically 
heterogenous than non-syndromic, but more than one locus has been identified for 
several syndromes (Avraham, 2001; Keats and Berlin, 1999). 
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Hearing loss can follow a pattern of autosomal recessive, autosomal dominant, X-linked 
and mitochondrial inheritance. Allelic mutations in some genes can cause recessive and 
dominant hearing loss and recessive hearing loss may be caused by a combination of 
two mutations in different genes from the same functional group (Schrijver, 2004). 
 
Autosomal dominant deafness loci are designated DFNA, autosomal recessive loci 
designated DFNB and X-linked loci, DFN. The loci are numbered according to the 
order in which they were mapped, DFNA1 being the first autosomal gene mapped in 
1992 (Van Camp and Smith, 1999). 
 
Approximately 70% of genetic hearing loss is non-syndromic in nature. The largest 
proportion (about 80%) is inherited in an autosomal recessive mode, 18% is inherited in 
an autosomal dominant mode and 2% is X-linked. Mitochondrial/maternal inheritance 
also contributes to a small (1%) proportion of NSHL (Avraham, 2001) (Table 1.2). 
 
Over 100 genes may be involved in non-syndromic hearing loss and the chromosomal 
location for over 80 have already been found. In the field of NSHL, 21 genes associated 
with autosomal recessive inheritance, 20 associated with autosomal dominant 
inheritance and one with X-linked recessive transmission have been identified and 
characterized (http://uia.ac.be/dnalab/hhh) with the most dramatic recent discovery is 
the high incidence of mutations found in the gap junction protein, connexin 26 (locus 
designation, GJB2) (Sobe et al., 2000). 
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Two additional genes have been implicated in hearing loss which are connexin 30 
(GJB6) (Xia et al., 1998) and connexin 31 (GJB3) (Liu et al., 2000), both in non-
syndromic hearing loss. 
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Table 1.2: Causes of hearing loss (Bitner-Glindzicz, 2002) 
 
Genetic 
(Syndromic and non-syndromic) 
Environmental 
 Autosomal recessive 
 Autosomal dominant 
 X-linked 
 Mitochondrial 
 
 Ototoxic medication 
 Severe neonatal jaundice 
 Head trauma 
 Noise exposure 
 Low birth weight 
 Infection: prenatal, e.g.: 
toxoplasmosis, rubella; postnatal, 
e.g. meningitis 
 Severe neonatal jaundice 
 Prematurity 
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1.6 Gap junction proteins in cochlea 
 
The gap junction proteins, encodes connexins which is a component of connexons that 
allows molecules to pass from cell to cell. This organization requires the membranes of 
two neighboring cells to come close to each other (White and Bruzzone, 1996). Six 
connexins form a connexon, which then aligns in the extracellular space to complete the 
formation of gap junction channels. Two different connexins can interact with each 
other to form homomeric (all the connexin are same), heteromeric (two different 
connexins within a single connexon) and heterotypic (two different homomeric 
connexons) channels, which differ in their content and spatial arrangement of connexins 
subunits, while gap junction channels which are made from only one type of connexin 
is called homotypic channel (Sosinsky, 1995; Chang et al., 2003) (Figure 1.3). 
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Figure 1.3: Schematic representation of connexins and gap junctions. (a) Blue and 
yellow connexins interact with each other to form homomeric, heteromeric and 
heterotypic channels, which differ in their content and spatial arrangement of connexins 
subunits. Adapted from Meşe et al., (2007) with modification (b) Six connexins form a 
connexon. Two connexons of neighbouring cells form pores; allow intercellular 
transport of small molecules (Wagner, 2008 - with modification) 
 
 
   
 
  a 
b 
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Connexin family members share a similar structural topology. Each connexin has four 
transmembrane domains (TM1-TM4) that constitute the pore of the channels, with two 
intercellular loops (IC1 and IC2) and two extracellular loops (EC1 and EC2). Two 
terminal tails, N- (NH2) and C- (COOH) termini are cytoplasmic. The length of the 
cytoplasmic C-terminus varies greatly among connexins and the cytoplasmic loop 
shows some variation in length. Otherwise the overall structure of the molecules is 
highly conserved (Bennett et al., 1991; Simon and Goodenough, 1998) (Figure 1.4). 
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Figure 1.4: Schematic representation of basic connexin (a) Schematic representation of 
connexin. TM1-TM4; transmembrane domains, EC1-EC2; extracellular loops, IC1-IC3; 
intercellular loops and N- and C-termini; terminal domains. Adapted from Simon and 
Goodenough, 1998, with modification (b) Schematic representation of connexin 26, 30 
and 31. The length of C-terminus show some variation, also the length of cytoplasmic 
loop. Other regions are highly conserved among connexins (Rabionet et al., 2000, with 
modification) 
 
b 
a 
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The amino terminus plays an important role in voltage gating, dynamically regulating 
gap junction properties by noncovalent or covalent modifications in the surrounding 
amino acids. The extracellular loops are critical for docking between two connexons 
and connexon compatibility. The transmembrane domains form the pore of the gap 
channel and it is important in channel permeability (Krutovskikh & Yamasaki, 2000). 
   
Connexin 26 and 30, encoded by GJB2 and GJB6 gene, which are highly expressed in 
epithelial supporting cells of the mammalian cochlea, have been speculated to have a 
crucial role in the recycling of potassium ions (K
+
) from the hair cells back to the 
endolymph of the cochlear duct. (Kikuchi et al., 1995; Petit et al., 2001). 
 
Cochlea, a structure in the inner ear, contains transduction machinery to sense the 
vibration transmitted from the middle ear after sound stimulus (Martinez et al., 2009) 
(Figure 1.5). Cochlea is formed by three adjacent and paralleled tubular compartments; 
scala media, scala tympani and scala vestibule. The epithelial cells, fibrocytes and 
receptor cells which are located in the wall of tubular compartments are the principal 
cellular components of cochlea. These compartments are filled with two types of fluid, 
endolymph and perilymph. The endolymph possesses a high concentration of potassium 
ion (K
+
) and low level of sodium ion (Na
+
)
 
fills the scala media. The perilymph contains 
high concentration of Na
+ 
and low K
+
 fills the scala vestibuli and scala tympani 
(Wangemann, 2006; Zhao et al., 2006) (Figure 1.6). 
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Figure 1.5: Flow diagram of human auditory pathway (http://eardoctors.org/med_info/images_med_info/earworks.gif and 
http://universe-review.ca/I10-85-cochlea.jpg)
1
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Figure 1.6: Schematic illustration indicating possible pathway for the transport of K
+
 in 
the cochlea (Kikuchi et al., 2000) 
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In the mammalian cochlea, there are two independent gap junction systems, epithelial 
cell gap junction system and connective tissue cell gap junction system, which are 
necessary for the normal hearing function (Zhao et al., 2006). The first system, the 
epithelial cell gap junction system, is mainly composed of all organ of Corti supporting 
cells, and also includes interdental cells in the spiral limbus and root cells within the 
spiral ligament. The second system, the connective tissue cell gap junction system, 
consists of strial intermediate cells, strial basal cells, fibrocytes in the spiral ligament, 
mesenchymal cells lining the bony otic capsule facing the scala vestibuli, mesenchymal 
dark cells in the supralimbal zone, and fibrocytes in the spiral limbus (Kikuchi et al., 
2000). 
 
Activation of hair cells by acoustic stimuli induces influx of K
+
 from the endolymph to 
sensory hair cells. This K
+
 is released basolaterally to the extracellular space of the 
organ of Corti, from which they enter the cochlear supporting cells. Once inside the 
supporting cells, the ions move via the epithelial cell gap junction system laterally to the 
lower part of the spiral ligament. The K
+ 
is released into the extracellular space of the 
spiral ligament by root cells and taken up by type II fibrocytes. This uptake incorporates 
K
+
 into the connective tissue gap junction system. Within the system, the K
+
 passes 
through the tight junctional barrier of the stria vascularis and are released within the 
intrastrial extracellular space. The marginal cells of the stria vascularis then take up K
+
 
and return it to the endolymphatic space, where it can be used again in sensory 
transduction (Kikuchi et al., 2000).  
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It is highly probable that mutations of connexin genes cause dysfunction of cochlear 
gap junctions and thereby interrupt K
+
 recirculation pathway (Kikuchi et al., 2000). 
Interruption of the recirculation may be caused by mutation in the connexin 26 (Cx26) 
and connexin 30 (Cx30) genes, which both connexins are functioned as epithelial cell 
gap junction system. 
 
1.7 Gap junction protein genes 
 
Autosomal recessive non-syndromic hearing loss make up about 80% of hereditary 
hearing loss (Avraham, 2001). The DFNB1 locus, which is located on chromosome 
13q11-12, was the first deafness recessive locus to be discovered (Avraham, 2001). The 
locus contains two genes which are GJB2 and GJB6 (Figure 1.7). The human 
connexins are classified by their molecular mass and by extent of sequence identity, 
which is indicated in the gene symbols for GJA, B and C subtypes. The connexin genes 
are very similar and contain their coding region within a single exon, separated from 5‟-
untranslated region (UTR) by an intron (Schrijver, 2004). 
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1.7.1 Gap junction protein beta-2 (GJB2) gene 
 
Gap junction protein beta-2 or GJB2 gene (Accession no.: M86849) encodes protein 
connexin 26 (Cx26), a gap junction protein of the beta group with a moleculer weight of 
26 kDa. The size of GJB2 gene is 2.2 kb with 2 exons and 1 intron. The coding 
sequence of GJB2 encompassed entirely by exon 2 and consists of 680 bp, which are 
translated into a protein with 226 amino acids including the stop codon (Kenneson et 
al., 2002) (Figure 1.8). Exon 1 is contained in the 5‟-UTR (del Castillo et al., 2003). 
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Figure 1.7: Location of GJB2 and GJB6 genes. Location of GJB2 gene; at long (q) arm 
of chromosome 13 between positions 11 and 12 and location of GJB6 gene; at long (q) 
arm of chromosome 13 at position 12 (http://ghr.nlm.nih.gov/gene=gjb2 and 
http://ghr.nlm.nih.gov/gene=gjb6). 
 
 
 
 
 
GJB2 and GJB6 gene 
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Figure 1.8: Schematic diagram of Cx26 with sequence of amino acids. Adapted from 
Martinez et al., 2009 with modification 
 
 
 
 
 
